Endometriosis is one of the most frequent gynecological disorders defined as the existence and growth of endometrial tissue outside the uterine cavity. Aim of this study was to evaluate the level of six oxidative stress markers in the serum of patients with and without endometriosis. This study included 46 women who were undergoing laparoscopy. The participants were divided into two groups based on their laparoscopic results. Thirty-one women had visually and histopathologically confirmed endometriosis, whereas 15 did not. The serum level of ADMA (asymmetric dimethylarginine), MCP1 (monocyte chemoattractant protein 1), MMP2 (matrix metalloproteinases 2), MMP9 (matrix metalloproteinases 9), RANTES (regulated upon activation, normal T cell expressed and presumably secreted), and VEGF-A (vascular endothelial growth factor) as oxidative stress markers were measured and compared between the two groups. No significant difference in the ADMA, MCP1, MMP2, MMP9, RANTES, and VEGF-A serum levels was detected between the entometriosis patients and controls. The disease stage did not affect any of the markers' level either. Women with endometriosis had menarche at an earlier age compared to controls [11.7 (SD 1.09) vs 12.6 (SD 1.4), p = 0.04)]. These results suggest that there is no association between endometriosis and increased oxidative stress. The elevation and possible role of oxidative stress markers in the diagnosis and pathogenesis of endometriosis should be evaluated in more extended studies.
Introduction
Endometriosis represents a chronic, benign gynecological disorder defined as the presence of ectopic endometrial tissue outside the uterus. Its appearance is most common in women of reproductive age (6-10%), and it is associated with dysmenorrhea, chronic lower abdominal pain, dyspareunia, and infertility [1, 2] . Regarding the role of menarche age on the development of endometriosis, the existing studies conclude to controversial results [3] [4] [5] . According to meta-analysis of case-control studies, early menarche is associated with a mild increased risk of endometriosis [3] . However, more recent published study concluded that menarche age is not related to the disease phenotype in a sample of women who were firstly operated for endometriosis [4] . Even though endometriosis is a complex and yet not fully understood condition, many studies indicate that oxidative stress (OS) and reactive oxygen species (ROS) might play a role in the pathogenesis of the disease. Oxidative stress is characterized by the production of ROS or free radicals through the activation of macrophages and polymorpho-nuclear leucocytes in patients with endometriosis. Normally, ROS production and antioxidants defense system are balanced through the neutralization of oxidants by the antioxidants. Elevated ROS in peripheral blood and peritoneal fluid of women with endometriosis results in excessive growth and adhesion of ectopic endometrial cells fostering the amplification of the disease [6, 7] .
Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthase which is produced by activated macrophages in women with endometriosis. Therefore, ADMA is associated with decreased NO levels [8, 9] .
Both monocyte chemoattractant protein-1 (MCP-1) and regulated upon activation normal T cell expressed and secreted (RANTES) belong to the family of chemokines, a special group of chemoattracant cytokines, which are involved in many physiological as well as pathological conditions of the female reproductive system [10] . MCP-1 is secreted by many different cell types such as monocytes, lymphocytes, and endothelial cells in response to inflammation and oxidative stress [11] . RANTES basically stimulates monocyte migration and chemotactic activity in the peritoneum [12] .
Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) comprise a small group of matrix metalloproteinases (MMPs), the group of gelatinases. MMPs are zinc-dependent endopeptidases that regulate the extracellular matrix (ECM) in tissues. MMP-2 and MMP-9 have the ability of degradation of type IV collagen. Additionally, many studies have proved that MMP-2 and MMP-9 play an important role in angiogenesis, metastasis, and invasion in many diseases such as cancer and endometriosis [13, 14] .
Vascular endothelial growth factor (VEGF) is a wellknown cytokin expressed by vascular endothelial cells and has been recognized as main angiogenic factor in the pathogenesis of endometriosis [15] .
Numerous researchers have focused on the oxidative stress markers found in the peritoneal fluid of women with endometriosis. However, there is little information about the levels of oxidative stress markers in the peripheral blood. The present study is an attempt to investigate and compare the serum levels of six oxidative stress markers-ADMA, MCP-1, MMP-2, MMP-9, RANTES, and VEGF-A-in women with and without endometriosis.
Material and Methods

Study Population
All female patients of reproductive age who were undergoing gynecological laparoscopy for evaluation of unexplained infertility, chronic pelvic pain, dyspareunia, ultrasonographically identified adnexal mass or for tubal ligation at the Second Department of Obstetrics and Gynecology, Aretaieion Hospital, University of Athens, between 2016 and 2018 were selected for participation in the study. Exclusion criteria were antioxidant or anti-inflammatory or hormonal treatment for at least 6 months before laparoscopy and high level of C-reactive protein level or white blood cell count (normal value, 3.6 to 9.6 × 10 3 mL), or elevated body temperature (> 37°C) before the operation (laparoscopy procedure).
Forty-six women, among 60 who were recruited for the study after sample estimation via power analysis methodology, were eligible and assigned for this study. More specifically, study sample was previously calculated via power analysis method. According to studies, total hydroxyperoxide levels were significantly higher during endometriosis. Based on this principle, we divided study participants into two groups, females with endometriosis (group A) and females without this condition (group B control group), with a ratio of A:B equal to 1.5. According to published data [16] , women with endometriosis had 10% higher total levels of hydroxyperoxide, compared to the control group. Given that a sample size of 53 women, allocated in two groups with or without endometriosis, provides 80% power of detecting a difference equal or bigger than 10% in total levels of hydroxyperoxide; our study sample size should be approximately 60 subjects. Two groups were created after the investigation of each patient for endometriotic foci through laparoscopy performed by the same surgeon. The first group was composed of 31 women with visually and histologically confirmed endometriosis, mean age 35.2 (7.4SD) years. According to the revised American Fertility Society classification, the patients were at stages I-II and stages III-IV. The second group was composed of 15 women without endometriosis, mean age 34.9 (5.3) years, and constituted the control group. The maximum age for our study sample was 42 years old.
In addition, all participants were interviewed by a medical practitioner, and details about medical history, family history of cardiovascular disease (CVD), gynecologic and obstetric history, as well as sociodemographic parameters were collected. In the morning after overnight fasting, 2 days before the laparoscopic procedure, peripheral blood samples were obtained from the 46 participants. Samples were centrifuged at 3000 rpm for 20 min, and serums were aliquoted and placed at − 80°C until measurement. Written informed consent was obtained from all the patients, and the study was performed with Institutional Review Board approval.
Laboratory Methods
Concentrations of six markers of oxidative stress were measured in the serum of 31 women with endometriosis and 15 women as the control group. These markers were ADMA (asymmetric dimethylarginine), MCP-1 (monocyte chemoattractant protein 1), MMP-2 (matrix metalloproteinases 2), MMP-9(matrix metalloproteinases 9), RANTES (Regulated upon Activation, Normal T cell Expressed and presumably Secreted), and VEGF-A (vascular endothelial growth factor).
RANTES measurements were performed with ELISA commercial kit (human RANTES ELISA Kit, catalog No. BMS287/2INST; Bender MedSystems GmbH, Vienna, Austria, Europe). The sensitivity of the test was 4.2 pg/ml, and the coefficient of variation (CV) for intra-and interassay were 6.9%, and 9.9% respectively. MMP-9 serum levels were determined in an ELISA with the use of commercial kit (human MMP9 ELISA Kit, catalog No. BMS2016/2 CE and BMS2016/2TENCE; Bender MedSystems GmbH, Vienna, Austria, Europe). The sensitivity of the test was 0.05 ng/ml, and the CV intra-and inter-assay were 7.3% and 10.2% respectively.
The level of MMP-2 in the serums was determined in an ELIZA with the use of commercial kit (human MMP2 ELISA Kit, catalog No. BBT0459R; BioVendor-Laboretoni medicina a.s. Modrice, Czech Republic). The sensitivity of the test was < 50 pg/ml, and the CV for intra-and inter-assay were 1.9% and 6.9 respectively.
ADMA measurements were performed with ELISA commercial kit (human ADMA ELISA Kit, cat. No. EA201/96; Diagnostica GMBH, Hamburg, Germany, Europe). The sensitivity of the method was 0.05 μmol/l, and the CV for intraand inter-assay were 6.05% and 9.45% respectively.
MCP1 serum level was determined in an ELISA with the use of commercial kit (human MCP1 ELISA Kit, cat, No. BMS281INSTCE; Bender MedSystems GmbH, Vienna, Austria, Europe). The sensitivity of the method was 2.31 pg/ ml, and the CV for intra-and inter-assay were 7.7% and 6.2% respectively.
VEGF-A measurements were performed with ELISA commercial kit (human VEGF-A ELISA Kit, cat. No. BMS277/ 2 CE and BMS277/2TENCE; Bender MedSystems GmbH, Vienna, Austria, Europe). The sensitivity of the method was 7.9 pg/ml, and the CV intra-and inter-assay were 6.2% and 4.3% respectively.
Statistics
Results are presented as means ± standard deviations (SDs). The SPSS Version 21 (Statistical Package for the Social Sciences, Chicago, IL, USA) was used for all analyses and a value of p < 0.05 was considered statistically significant. Finally, the Student's t test, analysis of variances and the χ2 test were used, as appropriate, in comparisons. Table 1 shows the demographic characteristics of the two groups. Women with endometriosis had menarche at an earlier age compared to controls [11.7 (SD 1.09) vs 12.6 (SD 1.4), p = 0.04). With regard to age, body mass index (BMI), parity, smoking, and family history of cardiovascular (CVD), no differences were observed between the two groups.
Results
There was no statistically significant difference between patients with endometriosis and controls concerning RANTES, VEGF-A, MMP-2, MMP-9, MCP-1, and ADMA serum levels as shown in Table 2 . No differences were detected between the stages of endometriosis relating to the oxidative stress markers either ( Table 3 ).
Discussion
Endometriosis represents an estrogen-depended inflammatory disease of the female genital tract which affects million women of fertile age and is characterized by the presence of endometrium implants outside the uterine cavity [18] . Chronic pelvic pain, dysmenorrhea, and infertility constitute the main clinical presentation of the disease caused by chronic inflammation and oxidative stress in the pelvis. Previous studies have reported that peritoneal ROS concentrations and oxidative stress markers have been found elevated in women with endometriosis [19, 20] . However, little is known about the status of oxidative stress markers in the serum of these women. The present study is an attempt to determine and compare the level of ADMA, MCP-1, MPP-2, MMP-9, RANTES, and VEGF in serum of women with and without endometriosis.
Endothelial dysfunction characterizes oxidative stress which can promote the production of ROS and reduction of nitric oxide. There is a connection between NO and ADMA as the second functions like an endogenous inhibitor of the first reducing the production of NO. Moreover, clinical studies have shown that the endothelial-monocyte relationship is mediated by ADMA improving the way enthothelial cells adhere to monocytes. In the present study, we tried to investigate the possible role of ADMA as a marker of oxidative stress in endometriosis. No significant difference was observed in serum ADMA between women with endometriosis and controls. Considering that plasma level of ADMA can change abruptly because of changes in estrogen level or even a meal with different fat concentration, we can give a probable explanation for the results [8, 21, 22] . The activation and recruitment of monocytes and macrophages into the peritoneal cavity of patients with endometriosis is one of the primary abnormalities of the disease. MCP-1 has the property to chemoattract macrophages and fibroblasts into the endometrium before menstruation [23] . That indicates a possible role in the pathogenesis of endometriosis through the incursion on endometriotic implants by macrophages in healthy tissue. Many investigators have proved that MCP-1 concentration is elevated in the peritoneal fluid of women with endometriosis. The serum level of MCP-1 nonetheless remains a controversial issue since half of studies show significant difference between the women with endometriosis and the control groups and the rest studies do not [24, 25] . In our study, no statistically significant difference was found between the two groups.
Still, the pathogenesis of the disease remains unclear. The most widely accepted theory for its mechanism is the implantation of endometrial cells due to retrograde menstruation where the blood flows through the fallopian tubes into the peritoneum. In addition to implantation, the extracellular matrix (ECM) of the peritoneal tissue gets destructed and reconstructed. MMP-2 and MMP-9 play a crucial role promoting the cell migration, infiltration, and invasion of endometrial cells through degradation of the ECM in endometriosis [13, 26] . There are deficient literature data about serum level of gelatinases in endometriosis, and the results of our study showed no differences in their concentrations between patients and controls. In peritoneal fluid, in contrast, MMP-2 and MMP-9 concentrations have been found elevated owing to activated macrophages and neutrophil leukocytes which secrete MMP-2 and MMP-9 in the peritoneal cavity [27, 28] .
RANTES belongs to the chemoattractant cytokins (chemokines) and has been found in endometriotic tissue and genital tract fluids [29] . It is involved in many inflammatory processes such as endometriosis and its basic function is to chemoattract monocytes, macrophages, and eosinophils inducing them to migrate. It has been reported concentrations of RANTES to be elevated in ectopic endometrium and RANTES to correlate with the stage of the disease. Unfortunately, to date, there are not many studies investigating the relationship of serum RANTES with endometriosis [30, 31] . In our attempt to bring to light the possible correlation between them, we found that RANTES levels were higher in women with endometriosis compared to controls but without statistically significant difference. As far as it concerns stages of the disease, serum RANTES was higher in patients with stage 3-4 endometriosis than in patients with stage 1-2 endometriosis. Considering that RANTES is produced and secreted by endometriotic stromal cells in the peritoneal cavity, we could give a possible reason why RANTES is found elevated in peritoneal fluid of women with endometriosis while there are no differences detected in their peripheral blood concentrations of the marker.
As previously referred, endometrial cells infiltrate in the peritoneal cavity through retrograde menstruation. Further, new blood vessels and nutrients are required for the development, progression, and maintenance of peritoneal endometriosis [17] . VEGF has been recognized as one of the main angiogenic factors expressed by ectopic endometriotic lessons and released into peritoneal fluid. Literature data present controversial results about the association between endometriosis and VEGF. Some studies demonstrate increased concentrations of VEGF in peritoneal fluid and serum of women with endometriosis while others show no differences between patients and controls. In the present study, no statistically significant difference was detected between the two groups with regard to serum VEGF. Another fact is that both macrophages and endometriotic lesions produce VEGF and release it in the peritoneal cavity which could explain the elevated concentrations of VEGF that have been found in the peritoneal fluid of patients compared to peripheral blood [32, 33] . Our study, found relationship between age at menarche and endometriosis. Early age at menarche may increase time exposure to menstruation during reproductive age and may increase the risk of endometriosis. In a systematic review and meta-analysis of case-control studies, authors found a small increased risk of endometriosis in women with early menarche [34] . Recently, Matalliotakis M et al. found an association between endometriosis in adolescent and young women and early menarche [35] .
Unfortunately, no clear conclusion could be drawn with regard to the role of ADMA, MCP-1, MMP-2, MMP-9, RANTES, and VEGF in endometriosis from this study. Environmental, genetic, immunologic, hormonal, and chemical factors interact with each other to develop and promote the disease. Therefore, many pathways exist to the pathogenesis of the disease which remains an enigmatic subject for the investigators. Future trials with bigger sample size that will target oxidative stress markers are necessary for the development of non-invasive diagnostic methods and effective treatment of endometriosis.
